Depo-Provera® and Breast Cancer Risk
February 21st, 2017|
Birth control has come a long way in the last 30 years. From oral medication to routine injections, women have a variety of options when it comes to contraception. However, not all forms of birth control are inherently safe. An injection-based birth control called Depo-Provera® has recently come under intense scrutiny due to a possible link between its extended use and breast cancer.
According to researchers at Fred Hutchinson Cancer Research Center, women who used Depo-Provera for more than one year had a 2.2-fold increased risk of developing breast cancer, specifically Invasive Ductal Carcinoma (IDC) and Invasive Lobular Carcinoma (ILC). Both forms of cancer can be fatal if undetected or left untreated.
At Ferrer, Poirot & Wansbrough, we know how devastating it can be to receive a cancer diagnosis. It immediately sends shockwaves throughout your life and the lives of those you love. It can make it worse knowing that a prescription drug, such as Depo-Provera, may have caused your cancer. That’s why we fight so hard to hold pharmaceutical companies accountable for the harmful medications they put on the market. For more than 30 year, we’ve been standing up for drug injury victims and fighting to get them the compensation they need to recover from their injuries.
If you or someone you love was diagnosed with breast cancer after taking Depo-Provera, call the drug injury lawyers at Ferrer, Poirot & Wansbrough today for a free evaluation of your claim. We’re ready to put more than 35 years worth of experience to work for you. Contact us today.